Italia markets close in 2 hours 9 minutes

Masimo Corporation (MASI)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a portafoglio
233,08-4,61 (-1,94%)
Alla chiusura: 04:00PM EST
231,00 -2,08 (-0,89%)
Preborsa: 08:58AM EST

Masimo Corporation

52 Discovery
Irvine, CA 92618
United States
949 297 7000
https://www.masimo.com

Settore/iHealthcare
SettoreMedical Instruments & Supplies
Impiegati a tempo pieno2.000

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Joseph E. KianiFounder, CEO & Chairman3,49M198,42M1965
Mr. Micah YoungExec. VP of Fin. & CFO762,48k2,72M1979
Mr. Bilal MuhsinChief Operating Officer1,02M6,48M1981
Dr. Steven J. BarkerChairman of Scientific Advisory Board & Chief Science Officer139,56kN/D1945
Mr. Thomas Samuel McClenahanExec. VP, Gen. Counsel & Corp. Sec.757,63k5,47M1973
Mr. Tao Leopold LevyExec. VP of Bus. Devel.605,07kN/D1974
Mr. Yongsam LeeExec. VP & Chief Information OfficerN/DN/D1965
Mr. Eli KammermanVP of Bus. Devel. & Investor RelationsN/DN/DN/D
Mr. Jon ColemanPres of Worldwide Sales, Professional Services & Medical AffairsN/DN/D1964
Mr. Anand SampathExec. VP of Operations & Clinical ResearchN/DN/D1966
Gli importi risalgono al giorno 31 dicembre 2020 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. The company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. The company offers coronavirus-2019 response and telehealth solutions; connectivity devices; and nasal high flow ventilation and neuromodulation solutions. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. Incorporated in 1989, the company is headquartered in Irvine, California.

Governance aziendale

L'ISS Governance QualityScore di Masimo Corporation al 26 settembre 2021 è 5. I criteri di valutazione fondamentali sono revisione: 6; Consiglio di Amministrazione: 8; diritti degli azionisti: 4; retribuzione: 3.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.